These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1332094)

  • 41. The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers.
    Silverstone PH; Rue JE; Franklin M; Hallis K; Camplin G; Laver D; Cowen PJ
    Int Clin Psychopharmacol; 1994 Sep; 9(3):173-8. PubMed ID: 7814826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy control subjects. Diurnal responses and nocturnal regulatory mechanisms.
    Schwartz PJ; Murphy DL; Wehr TA; Garcia-Borreguero D; Oren DA; Moul DE; Ozaki N; Snelbaker AJ; Rosenthal NE
    Arch Gen Psychiatry; 1997 Apr; 54(4):375-85. PubMed ID: 9107154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
    Mueller EA; Murphy DL; Sunderland T
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1179-84. PubMed ID: 4055985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.
    Benjamin J; Greenberg BD; Murphy DL
    Psychopharmacology (Berl); 1996 Sep; 127(2):140-9. PubMed ID: 8888380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hormonal and temperature responses to the 5-HT1A receptor agonist flesinoxan in normal volunteers.
    Pitchot W; Wauthy J; Hansenne M; Pinto E; Fuchs S; Reggers J; Legros JJ; Ansseau M
    Psychopharmacology (Berl); 2002 Oct; 164(1):27-32. PubMed ID: 12373416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A dose-response study of intravenous m-chlorophenylpiperazine in normal subjects.
    Kalus O; Wetzler S; Kahn RS; Asnis GM; van Praag HM
    Psychopharmacology (Berl); 1992; 106(3):388-90. PubMed ID: 1533289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Central serotonergic effects of m-chlorophenylpiperazine (mCPP) among normal control adolescents.
    Ghaziuddin N; Welch K; Greden J
    Neuropsychopharmacology; 2003 Jan; 28(1):133-9. PubMed ID: 12496949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects.
    Broocks A; Meyer T; Gleiter CH; Hillmer-Vogel U; George A; Bartmann U; Bandelow B
    Psychopharmacology (Berl); 2001 May; 155(3):234-41. PubMed ID: 11432685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
    Abel KM; O'Keane V; Murray RM
    Br J Psychiatry; 1996 Jan; 168(1):57-60. PubMed ID: 8770429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjects.
    Lawlor BA; Sunderland T; Hill JL; Mellow AM; Molchan SE; Mueller EA; Jacobsen FM; Murphy DL
    Psychiatry Res; 1989 Jul; 29(1):1-10. PubMed ID: 2772095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls.
    Zohar J; Mueller EA; Insel TR; Zohar-Kadouch RC; Murphy DL
    Arch Gen Psychiatry; 1987 Nov; 44(11):946-51. PubMed ID: 3675134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E; DeCaria CM; Nitescu A; Gully R; Suckow RF; Cooper TB; Gorman JM; Klein DF; Liebowitz MR
    Arch Gen Psychiatry; 1992 Jan; 49(1):21-8. PubMed ID: 1728249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study.
    Pitchot W; Wauthy J; Legros JJ; Ansseau M
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):151-5. PubMed ID: 15013031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of the serotonin agonist, MK-212, on body temperature in schizophrenia.
    Lee HS; Bastani B; Friedman L; Ramirez L; Meltzer HY
    Biol Psychiatry; 1992 Mar; 31(5):460-70. PubMed ID: 1581424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo.
    de Leeuw AS; Westenberg HG
    J Psychiatr Res; 2008 Sep; 42(11):894-901. PubMed ID: 18533183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.
    Buydens-Branchey L; Branchey M; Fergeson P; Hudson J; McKernin C
    Alcohol Clin Exp Res; 1997 Apr; 21(2):220-6. PubMed ID: 9113256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The behavioral effect of m-chlorophenylpiperazine (mCPP) and methylphenidate in first-episode schizophrenia and normal controls.
    Koreen AR; Lieberman JA; Alvir J; Chakos M
    Neuropsychopharmacology; 1997 Jan; 16(1):61-8. PubMed ID: 8981389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroendocrine and temperature effects of nefazodone in healthy volunteers.
    Walsh AE; Hockney RA; Campling G; Cowen PJ
    Biol Psychiatry; 1993 Jan; 33(2):115-9. PubMed ID: 8382534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hostility is associated with a low prolactin response to meta-chlorophenylpiperazine in abstinent alcoholics.
    Handelsman L; Holloway K; Kahn RS; Sturiano C; Rinaldi PJ; Bernstein DP; Siever L; Gabriel S; Cooper TB
    Alcohol Clin Exp Res; 1996 Aug; 20(5):824-9. PubMed ID: 8865955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of meta-chlorophenylpiperazine (mCPP), a central serotonin agonist and vascular serotonin receptor antagonist, on blood pressure in SHR.
    Cohen ML; Kurz KD; Fuller RW
    Clin Exp Hypertens A; 1987; 9(10):1549-65. PubMed ID: 3677442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.